Hideaki Miyachi, M.D., Ph.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nasopharynx | 2 | 2024 | 420 | 1.470 |
Why?
|
Psoriasis | 4 | 2023 | 926 | 1.190 |
Why?
|
Bronchiolitis | 2 | 2024 | 492 | 1.170 |
Why?
|
Pemphigoid, Bullous | 2 | 2023 | 110 | 0.950 |
Why?
|
Onychomycosis | 1 | 2024 | 50 | 0.910 |
Why?
|
Skin Diseases, Vesiculobullous | 2 | 2023 | 83 | 0.910 |
Why?
|
Mycetoma | 1 | 2023 | 18 | 0.880 |
Why?
|
Pemphigus | 1 | 2022 | 107 | 0.760 |
Why?
|
Dermatomycoses | 1 | 2021 | 45 | 0.740 |
Why?
|
Respiratory Sounds | 1 | 2024 | 702 | 0.700 |
Why?
|
Receptors, Interleukin-1 | 1 | 2021 | 260 | 0.690 |
Why?
|
Hand Dermatoses | 1 | 2019 | 61 | 0.670 |
Why?
|
Antifungal Agents | 1 | 2024 | 761 | 0.650 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2023 | 667 | 0.620 |
Why?
|
Japan | 4 | 2024 | 1418 | 0.610 |
Why?
|
Interleukin-17 | 2 | 2022 | 925 | 0.610 |
Why?
|
Immunoglobulin E | 1 | 2024 | 1506 | 0.600 |
Why?
|
Candidiasis, Cutaneous | 1 | 2017 | 6 | 0.580 |
Why?
|
Syphilis | 1 | 2019 | 243 | 0.550 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2021 | 582 | 0.550 |
Why?
|
Keratinocytes | 1 | 2021 | 876 | 0.540 |
Why?
|
Exanthema | 1 | 2021 | 503 | 0.530 |
Why?
|
Hair Diseases | 1 | 2016 | 72 | 0.520 |
Why?
|
Dermoscopy | 1 | 2016 | 73 | 0.510 |
Why?
|
Cellulitis | 1 | 2017 | 206 | 0.490 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2016 | 234 | 0.490 |
Why?
|
Recurrence | 2 | 2024 | 8513 | 0.450 |
Why?
|
Scalp | 1 | 2016 | 391 | 0.430 |
Why?
|
Dermatologic Agents | 1 | 2017 | 313 | 0.420 |
Why?
|
Biological Products | 1 | 2021 | 947 | 0.390 |
Why?
|
Organomercury Compounds | 1 | 2009 | 16 | 0.350 |
Why?
|
Thymine | 1 | 2009 | 69 | 0.340 |
Why?
|
Coordination Complexes | 1 | 2009 | 73 | 0.320 |
Why?
|
Databases, Factual | 1 | 2024 | 8094 | 0.310 |
Why?
|
Lung Diseases, Interstitial | 1 | 2017 | 940 | 0.310 |
Why?
|
Electrons | 1 | 2009 | 264 | 0.300 |
Why?
|
Mercury | 1 | 2009 | 289 | 0.280 |
Why?
|
Asthma | 1 | 2024 | 6293 | 0.240 |
Why?
|
Foot Dermatoses | 1 | 2024 | 46 | 0.230 |
Why?
|
Paraffin Embedding | 1 | 2023 | 306 | 0.200 |
Why?
|
Administration, Topical | 1 | 2024 | 704 | 0.200 |
Why?
|
Skin Neoplasms | 2 | 2024 | 5864 | 0.190 |
Why?
|
Formaldehyde | 1 | 2023 | 361 | 0.190 |
Why?
|
Head and Neck Neoplasms | 1 | 2016 | 2931 | 0.190 |
Why?
|
Malassezia | 1 | 2021 | 7 | 0.190 |
Why?
|
Inpatients | 2 | 2023 | 2569 | 0.180 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9264 | 0.180 |
Why?
|
Insurance Claim Review | 1 | 2024 | 746 | 0.170 |
Why?
|
Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2019 | 42 | 0.170 |
Why?
|
Candidiasis | 1 | 2022 | 367 | 0.170 |
Why?
|
Candida albicans | 1 | 2022 | 375 | 0.160 |
Why?
|
Fertility Agents, Female | 1 | 2019 | 101 | 0.160 |
Why?
|
Hemangioma | 1 | 2024 | 727 | 0.160 |
Why?
|
Skin | 2 | 2023 | 4506 | 0.150 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2019 | 232 | 0.140 |
Why?
|
Lymphocytes | 2 | 2022 | 2614 | 0.130 |
Why?
|
Administration, Oral | 1 | 2024 | 4040 | 0.130 |
Why?
|
Drug Costs | 1 | 2024 | 1198 | 0.130 |
Why?
|
Drug Prescriptions | 1 | 2024 | 1673 | 0.120 |
Why?
|
Metals | 2 | 2009 | 713 | 0.120 |
Why?
|
Eye Diseases | 1 | 2019 | 658 | 0.110 |
Why?
|
Lipids | 1 | 2024 | 3345 | 0.110 |
Why?
|
Infertility, Female | 1 | 2019 | 764 | 0.110 |
Why?
|
Spectrophotometry, Ultraviolet | 2 | 2009 | 199 | 0.100 |
Why?
|
Humans | 14 | 2024 | 768970 | 0.100 |
Why?
|
Base Pairing | 2 | 2009 | 139 | 0.100 |
Why?
|
Immunity, Innate | 2 | 2022 | 3080 | 0.100 |
Why?
|
Infant | 2 | 2024 | 36556 | 0.100 |
Why?
|
Quantum Theory | 1 | 2011 | 68 | 0.090 |
Why?
|
Elasticity Imaging Techniques | 1 | 2016 | 398 | 0.090 |
Why?
|
Child, Preschool | 2 | 2024 | 42683 | 0.090 |
Why?
|
Aged | 5 | 2024 | 171786 | 0.090 |
Why?
|
Health Care Costs | 1 | 2024 | 3270 | 0.090 |
Why?
|
DNA | 3 | 2009 | 7214 | 0.090 |
Why?
|
Silver | 1 | 2011 | 119 | 0.090 |
Why?
|
Acute Disease | 1 | 2021 | 7245 | 0.090 |
Why?
|
Absorption | 1 | 2009 | 244 | 0.080 |
Why?
|
Uracil | 1 | 2011 | 210 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4207 | 0.080 |
Why?
|
Prospective Studies | 2 | 2024 | 54962 | 0.080 |
Why?
|
Female | 8 | 2024 | 397515 | 0.080 |
Why?
|
Sulfur | 1 | 2009 | 158 | 0.080 |
Why?
|
Disease Progression | 2 | 2024 | 13674 | 0.080 |
Why?
|
Cytokines | 1 | 2024 | 7453 | 0.080 |
Why?
|
Organometallic Compounds | 1 | 2011 | 648 | 0.070 |
Why?
|
Risk Factors | 2 | 2024 | 74976 | 0.070 |
Why?
|
Nucleotides | 1 | 2009 | 455 | 0.070 |
Why?
|
Models, Chemical | 1 | 2009 | 611 | 0.070 |
Why?
|
Copper | 1 | 2008 | 369 | 0.070 |
Why?
|
Chronic Disease | 1 | 2021 | 9384 | 0.070 |
Why?
|
Young Adult | 2 | 2024 | 60131 | 0.060 |
Why?
|
Inflammation | 2 | 2022 | 10868 | 0.060 |
Why?
|
Hospitalization | 1 | 2024 | 10847 | 0.060 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2024 | 47 | 0.060 |
Why?
|
Male | 4 | 2024 | 365203 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 13021 | 0.060 |
Why?
|
Infant, Newborn | 1 | 2024 | 26428 | 0.060 |
Why?
|
Remission, Spontaneous | 1 | 2024 | 385 | 0.050 |
Why?
|
Retrospective Studies | 2 | 2022 | 81903 | 0.050 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2022 | 165 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7478 | 0.050 |
Why?
|
Clomiphene | 1 | 2019 | 72 | 0.040 |
Why?
|
Epidermis | 1 | 2022 | 539 | 0.040 |
Why?
|
Receptors, Progesterone | 1 | 2024 | 1159 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15951 | 0.040 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2019 | 156 | 0.040 |
Why?
|
Plasma Exchange | 1 | 2019 | 159 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13594 | 0.040 |
Why?
|
Receptors, Androgen | 1 | 2024 | 1091 | 0.040 |
Why?
|
Mice | 2 | 2022 | 82072 | 0.040 |
Why?
|
Chorionic Gonadotropin | 1 | 2019 | 458 | 0.040 |
Why?
|
Treatment Outcome | 1 | 2023 | 65480 | 0.030 |
Why?
|
Adolescent | 1 | 2024 | 89244 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2024 | 2252 | 0.030 |
Why?
|
Child | 1 | 2024 | 80960 | 0.030 |
Why?
|
Adult | 3 | 2024 | 223851 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2120 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20776 | 0.030 |
Why?
|
Animals | 2 | 2022 | 169335 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2016 | 59739 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2019 | 2167 | 0.020 |
Why?
|
Middle Aged | 1 | 2024 | 223737 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1811 | 0.020 |
Why?
|
Thermodynamics | 1 | 2011 | 591 | 0.020 |
Why?
|
Cations, Divalent | 1 | 2009 | 167 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6320 | 0.020 |
Why?
|
Models, Molecular | 2 | 2009 | 5404 | 0.020 |
Why?
|
Molecular Structure | 1 | 2011 | 1885 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2022 | 14484 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 22379 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 30265 | 0.010 |
Why?
|